Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)

Historic Inventory for Aclaris Therapeutics (ACRS) over the last 2 years, with Q3 2019 value amounting to $189000.0.

  • Aclaris Therapeutics' Inventory fell 8189.66% to $189000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $189000.0, marking a year-over-year decrease of 8189.66%. This contributed to the annual value of $791000.0 for FY2018, which is N/A changed from last year.
  • As of Q3 2019, Aclaris Therapeutics' Inventory stood at $189000.0, which was down 8189.66% from $185000.0 recorded in Q2 2019.
  • In the past 5 years, Aclaris Therapeutics' Inventory ranged from a high of $1.0 million in Q3 2018 and a low of $185000.0 during Q2 2019